Clinical Pharmacology and Therapeutics

  1532-6535

  0009-9236

  Mỹ

Cơ quản chủ quản:  Wiley-Blackwell , WILEY

Lĩnh vực:
Pharmacology (medical)Pharmacology

Các bài báo tiêu biểu

A method for estimating the probability of adverse drug reactions
Tập 30 Số 2 - Trang 239-245 - 1981
Claudio A. Naranjo, Usoa E. Busto, Edward M. Sellers, Paul Sandor, Inés Ruiz, Eve A. Roberts, E Janecek, C Domecq, D J Greenblatt
Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework
Tập 69 Số 3 - Trang 89-95 - 2001
Arthur J. Atkinson, Wayne A. Colburn, Victor G. DeGruttola, David L. DeMets, Gregory J. Downing, Daniel F. Hoth, John A. Oates, Carl C. Peck, Robert T. Schooley, Bert Spilker, Janet Woodcock, Scott L. Zeger
A physiological approach to hepatic drug clearance
Tập 18 Số 4 - Trang 377-390 - 1975
Grant R. Wilkinson, David G. Shand
A physiological approach has been developed recognizing that hepatic blood flow, the activity of the overall elimination process (intrinsic clearance), drug binding in the blood, and the anatomical arrangement of the hepatic circulation are the major biological determinants of hepatic drug clearance. This approach permits quantitative prediction of both the unbound and total drug concentration/time relationships in the blood after intravenous and oral administration, and any changes that may occur as a result of alterations in the above biological parameters. These considerations have led to a classification of drug metabolism based on the hepatic extraction ratio. The proposed classification allows prediction and interpretation of the effects of individual variations in drug‐metabolizing activity, route of administration, pharmacokinetic interactions, and disease states on hepatic drug elimination.
Pharmacogenomics Knowledge for Personalized Medicine
Tập 92 Số 4 - Trang 414-417 - 2012
Michelle Whirl‐Carrillo, Ellen M. McDonagh, Joan M. Hebert, Li Gong, Katrin Sangkuhl, Caroline F. Thorn, Russ B. Altman, Teri E. Klein
Clinical biostatistics: LIV. The biostatistics of concordance
Tập 29 Số 1 - Trang 111-123 - 1981
Michael S. Kramer, Alvan R. Feinstein
Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man
Tập 12 Số 2part1 - Trang 245-258 - 1971
William R. Martin, Jewell W. Sloan, Joseph D. Sapira, Donald R. Jasinski
Five centrally acting sympathomimetic amines, d‐amphetamine, d‐methamphetamine, ephedrine, phenmetrazine, and methylphenidate, were studied in man. All of these agents increased blood pressure and respiratory rate, produced similar types of subiective changes, and increased the excretion of epinephrine. With regard to these parameters, there was a high concordance between estimates of their relative potencies. The concordance between the potency estimates for the different parameters suggests, but does not prove, that these five agents share a common mode of central action. Further, if the peripheral modes of action as elucidated by animal studies are true for man, this study suggests that it is unlikely that their central actions in man are a consequence of the release of norepinephrine in the brain.
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for <i>CYP2D6</i> and <i>CYP2C19</i> Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors
Tập 98 Số 2 - Trang 127-134 - 2015
J. Kevin Hicks, JR Bishop, Katrin Sangkuhl, Daniel J. Müller, Yuan Ji, SG Leckband, JS Leeder, Ronald L. Graham, DL Chiulli, Adrián LLerena, TC Skaar, Stuart A. Scott, Julia Kirchheiner, Teri E. Klein, KE Caudle, Andrea Gaedigk
Selective serotonin reuptake inhibitors (SSRIs) are primary treatment options for major depressive and anxiety disorders. CYP2D6 and CYP2C19 polymorphisms can influence the metabolism of SSRIs, thereby affecting drug efficacy and safety. We summarize evidence from the published literature supporting these associations and provide dosing recommendations for fluvoxamine, paroxetine, citalopram, escitalopram, and sertraline based on CYP2D6 and/or CYP2C19 genotype (updates at www.pharmgkb.org).
Nicotine absorption and cardiovascular effects with smokeless tobacco use: Comparison with cigarettes and nicotine gum
Tập 44 Số 1 - Trang 23-28 - 1988
Neal L. Benowitz, Hervé Porchet, Lewis B. Sheiner, Peyton Jacob
Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: Consequences for pravastatin pharmacokinetics
Tập 73 Số 6 - Trang 554-565 - 2003
Yohei Nishizato, Ichiro Ieiri, H Suzuki, Miyuki Kimura, Kiyoshi Kawabata, Takeshi Hirota, Hiroshi Takane, Shin Irie, Hiroyuki Kusuhara, Yoko Urasaki, Akinori Urae, Kenji Otsubo, Yuichi Sugiyama